108 related articles for article (PubMed ID: 3152918)
81. Long-term survival after autologous bone marrow transplantation for follicular lymphoma in first remission.
Brown JR; Feng Y; Gribben JG; Neuberg D; Fisher DC; Mauch P; Nadler LM; Freedman AS
Biol Blood Marrow Transplant; 2007 Sep; 13(9):1057-65. PubMed ID: 17697968
[TBL] [Abstract][Full Text] [Related]
82. Autologous bone marrow transplantation. The influence of prolonged cytotoxic chemotherapy.
Schaefer UW; Nowrousian MR; Ohl S; Boecker WR; Scheulen ME; Schilcher B; Schmidt CG
Haematol Blood Transfus; 1980; 25():275-83. PubMed ID: 7021345
[No Abstract] [Full Text] [Related]
83. Successful adoptive immunotherapy of minimal residual disease after chemoradiotherapy and transplantation of bone marrow purged of leukaemia with mafosfamide.
Skórski T; Kawalec M; Kawiak J
Cancer Immunol Immunother; 1990; 32(1):71-4. PubMed ID: 2289201
[TBL] [Abstract][Full Text] [Related]
84. Preparation of autologous bone marrow grafts for cryopreservation using the AS104 cell separator.
Rick O; Heuft HG; Wittmann G; Blasczyk R; Huhn D; Schwella N
J Clin Apher; 1997; 12(4):179-82. PubMed ID: 9483179
[TBL] [Abstract][Full Text] [Related]
85. Hematologic engraftment and immune reconstitution posttransplantation with anti-B1 purged autologous bone marrow.
Anderson KC; Ritz J; Takvorian T; Coral F; Daley H; Gorgone BC; Freedman AS; Canellos GP; Schlossman SF; Nadler LM
Blood; 1987 Feb; 69(2):597-604. PubMed ID: 3542080
[TBL] [Abstract][Full Text] [Related]
86. Autologous bone marrow transplantation with immunotoxin-purged marrow for advanced multiple myeloma.
Gobbi M; Cavo M; Tazzari PL; Dinota A; Tassi C; Bontadini A; Albertazzi L; Miggiano C; Rizzi S; Rosti G
Eur J Haematol Suppl; 1989; 51():176-81. PubMed ID: 2627989
[TBL] [Abstract][Full Text] [Related]
87. Rapid and complete hemopoietic reconstitution following combined transplantation of autologous blood and bone marrow cells. A changing role for high dose chemo-radiotherapy?
Gianni AM; Bregni M; Siena S; Villa S; Sciorelli GA; Ravagnani F; Pellegris G; Bonadonna G
Hematol Oncol; 1989; 7(2):139-48. PubMed ID: 2646198
[TBL] [Abstract][Full Text] [Related]
88. Antiproliferative activity of 2-[N, N-bis-(2-chloroethyl)-amino]-4-[2-sulfonato-ethylthio]-tetrah ydr o-2H-1 , 3,2-oxazaphosphorine-2-oxide cyclohexamine (ASTA Z 7557, INN mafosfamide) against human and murine tumor cells in vitro.
Kovach JS; Svingen PA
Invest New Drugs; 1984; 2(2):155-9. PubMed ID: 6469509
[TBL] [Abstract][Full Text] [Related]
89. Early bone marrow transplantation for patients with potentially curable malignancies.
Armitage JO
Ann Oncol; 1991 Oct; 2(9):617-8. PubMed ID: 1742214
[No Abstract] [Full Text] [Related]
90. Busulfan-melphalan in high-risk neuroblastoma: the 30-year experience of a single institution.
Proust-Houdemont S; Pasqualini C; Blanchard P; Dufour C; Benhamou E; Goma G; Semeraro M; Raquin MA; Hartmann O; Valteau-Couanet D
Bone Marrow Transplant; 2016 Aug; 51(8):1076-81. PubMed ID: 27042850
[TBL] [Abstract][Full Text] [Related]
91. Autologous hematopoietic stem cell transplantation following high dose chemotherapy for non-rhabdomyosarcoma soft tissue sarcomas.
Peinemann F; Smith LA; Bartel C
Cochrane Database Syst Rev; 2013 Aug; 2013(8):CD008216. PubMed ID: 23925699
[TBL] [Abstract][Full Text] [Related]
92. Potential therapeutic role of cisplatinum in autologous bone marrow transplantation: in vitro eradication of neuroblastoma cells from bone marrow.
Bettan-Renaud L; de Vathaire F; Bénard J; Morardet N; Pauzie N; Bayet S; Hartmann O; Parmentier C
Br J Cancer; 1989 Oct; 60(4):529-32. PubMed ID: 2803923
[TBL] [Abstract][Full Text] [Related]
93. The use of recombinant cytokines for enhancing immunohematopoietic reconstitution following bone marrow transplantation. II. The influence of lymphokines on CFU-GM colonies from human untreated, ASTA-Z or Campath-1M treated bone marrow.
Mumcuoglu M; Naparstek E; Slavin S
Bone Marrow Transplant; 1990 Mar; 5(3):153-8. PubMed ID: 2184907
[TBL] [Abstract][Full Text] [Related]
94. The use of recombinant cytokines for enhancing immunohematopoietic reconstitution following bone marrow transplantation. I. Effects of in vitro culturing with IL-3 and GM-CSF on human and mouse bone marrow cells purged with mafosfamide (ASTA-Z).
Slavin S; Mumcuoglu M; Landesberg-Weisz A; Kedar E
Bone Marrow Transplant; 1989 Sep; 4(5):459-64. PubMed ID: 2676042
[TBL] [Abstract][Full Text] [Related]
95. Hemopoietic reconstitution after repeated autologous transplantation with mafosfamide-purged marrow.
Beaujean F; Hartmann O; Benhamou E; Lemerle J; Duedari N
Bone Marrow Transplant; 1989 Sep; 4(5):537-41. PubMed ID: 2790332
[TBL] [Abstract][Full Text] [Related]
96. Analysis of factors predicting speed of hematologic recovery after transplantation with 4-hydroperoxycyclophosphamide-purged autologous bone marrow grafts.
Rowley SD; Piantadosi S; Marcellus DC; Jones RJ; Davidson NE; Davis JM; Kennedy J; Wiley JM; Wingard JR; Yeager AM
Bone Marrow Transplant; 1991 Mar; 7(3):183-91. PubMed ID: 2059755
[TBL] [Abstract][Full Text] [Related]
97. Bone marrow purging with mafosfamide--a critical survey.
Sindermann H; Peukert M; Hilgard P
Blut; 1989 Nov; 59(5):432-41. PubMed ID: 2684298
[TBL] [Abstract][Full Text] [Related]
98. Incubation of autologous bone marrow graft with ASTA Z 7557: comparative studies of hematological reconstitution after purged or nonpurged bone marrow transplantation.
Beaujean F; Hartmann O; Pico J; Parmentier C; Hayat M; Lemerle J; Duédari N
Pediatr Hematol Oncol; 1987; 4(2):105-15. PubMed ID: 3152918
[TBL] [Abstract][Full Text] [Related]
99.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
100.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
